In recent years there has been increasing evidence that iron plays an important role in promoting tissue injury i To whom correspondence should be addressed. 78 at sites of inflammation (1) . This may occur secondary to the promotion of lipid peroxidation reactions or ironcatalyzed hydroxyl radical ('OH) formation via a Fenton reaction. However, under normal physiologic conditions, free iron does not exist in plasma or extracellular fluids and is not readily available for participation in biological reactions. Iron (Fe3+) is carried in the vertebrate bloodstream bound to transferrin in a ternary complex involving iron, transferrin, and bicarbonate (2-6) and is unable to promote oxidant-induced tissue injury in this bound state.
A most challenging problem in transferrin chemistry is the identification of mechanisms by which transferrin is induced to release iron (7) . Reduction of Fe3+ to ferrous iron (Fe"), which binds weakly to transferrin, is one mechanism for the release of free iron from transferrin (3, 4, 8) . The susceptibility of transferrin-bound Fe3+ to reduction can be enhanced by multiple factors. Under conditions of increasing hydrogen ion concentration, the Fe3+ . transferrin . bicarbonate complex experiences a conformational change, resulting in a decrease in binding affinity of transferrin for iron (2, 9-11). Theoretically, Fe3+, which is buried in the protein at physiologic pH (7.4), becomes more accessible to reduction, following conformational changes resulting from interaction of transferrin with hydrogen ion (12) (13) (14) .
Phagocytic cells, including human polymorphonuclear leukocytes (PMNs),' can release reactive oxygen metabolites including superoxide anion (0;) following activation (15 (22) . Transferrin, at physiologic levels of iron saturation, was then utilized in assays using methodology previously described for holosaturated transferrin.
Release ofFe3' from transferrin. The release of Fe3+ from transferrin by conditioned media from unstimulated and PMA-stimulated PMNs was determined. PMNs (2.5 X 106/ml) were incubated with SOD (90 U/ml final) and catalase (100 U/ml final) in the presence and absence of PMA (100 rig/ml final) for 10 min. Following centrifugation (3OOg, 10 min, 22'C), PMN-conditioned media (lo6 cell equivalents) was incubated with transferrin (0.060 mM final) at specific pH values in the presence of deferoxamine (10 mM final) in a shaking water bath (37"C, 20 min). The release of ferric iron from transferrin was monitored spectrophotometrically by the decrease in absorbance of transferrin at 295 nm, as previously described 
RESULTS
The ability of PMNs to secrete 0, at pH 7.4 in response to stimulation with PMA (100 rig/ml final) was determined. While unstimulated PMNs secreted negligible amounts of 0, (4 nmol/min), following stimulation with PMA (100 rig/ml final), the initial rate of 0; secreted by lo6 PMNs was 12.04 -t 0.77 nmol O;/min (n = 8). This is consistent with previously published reports (23). The effect of the presence of transferrin on PMN respiratory burst was also determined. Results of these experiments (data not shown) indicate that inclusion of transferrin in the reaction does not alter the rate of oxygen consumption by unstimulated or PMA-stimulated PMNs.
The ability of unstimulated and PMA-stimulated PMNs to facilitate the release of Fe2+ from holosaturated transferrin at pH 7.4 was assessed (Table I) . While unstimulated PMNs facilitated the release of minimal amounts of iron (0.11 nmol) from holosaturated transferrin (98%), stimulation of PMNs with PMA (100 ng/ ml, final) enhanced the release of Fe2+ from transferrin approximately eightfold. Dialysis of holosaturated transferrin in 0.1 M NaCIO, prior to use did not significantly alter the ability of PMA-stimulated PMNs to facilitate the release of Fe2+ from transferrin (data not shown). Similar results were also obtained in reactions in the absence of catalase (data not shown). Addition of SOD (90 U/ml) to PMA-stimulated PMNs prior to incubation resulted in the release of a small amount of iron (0.17 nmol) from holosaturated transferrin, while incubation of PMAstimulated PMNs with heat-inactivated SOD (8O"C, 60 min) failed to significantly inhibit the release of Fe2+ from transferrin by PMA-stimulated PMNs (P > 0.05). These results suggest that the release of Fe2+ from holosaturated The ability of PMN-derived extracellular 0; to facilitate the release of Fe2+ from transferrin at physiologic levels of iron saturation (32%) and pH 7.4 was determined. In contrast to holosaturated transferrin, incubation of unstimulated or PMA-stimulated PMNs with partially iron-saturated transferrin failed to increase the release of Fe2+ at physiologic pH ( Table I) .
The effect of decreasing the pH (by addition of HCl) on the release of Fe'+ from transferrin was assessed (Table  II) saturated transferrin at pH 6.6 and 6.2 was also inhibited by SOD (Table II) and occurred despite a pH-dependent decrease in extracellular 0, generation (Fig. 1) .
In further experiments, a more detailed study on the effect of decreasing pH on the release of ferrous iron from transferrin at physiologic levels of iron saturation was performed. For these studies, PMA-stimulated neutrophils were incubated with transferrin at physiologic levels of iron saturation (39% saturated) at 0.2 pH increments between pH 6.6 and 7.4. At pH 6.8,0.59 nmol of Fe'+ was released by PMA-stimulated neutrophils compared to 0.28 nmol of Fe2+ released from transferrin in the presence of unstimulated neutrophils. At pH 7.0, 7.2, and 7.4 PMAstimulated PMNs did not facilitate the release of enhanced amounts of Fe'+ from transferrin. Results of these experiments indicate that neutrophil-derived superoxide ion facilitates the release of enhanced amounts of ferrous iron from transferrin at pHs equal to and less than pH 6.8.
To determine if PMN-derived 0, facilitated the release of Fe3+ from transferrin, unstimulated and PMA-stimulated PMNs were incubated with holosaturated transferrin and deferoxamine (a Fe 3+ chelator) in the presence and absence of SOD. The release of Fe3+ from holosaturated transferrin was assessed spectrophotometrically by the formation of a Fe3+-deferoxamine complex in PMNconditioned media. Results of these experiments (data not shown) indicate that equivalent amounts of Fe3' are released from transferrin by unstimulated and PMAstimulated PMNs. To further address the ability of secretory products derived from PMA-stimulated PMNs to enhance Fe3+ release from transferrin, conditioned media from unstimulated and PMA-stimulated PMNs was incubated with iron-saturated transferrin (98%) and partially saturated transferrin (34% + 1.73) in the presence of deferoxamine (Table III) . As indicated by the decrease in absorbance of transferrin at 295 nm, conditioned media from unstimulated or PMA-stimulated PMNs was equally effective in facilitating the release of Fe3+ from transferrin, suggesting that secretory products of stimulated PMNs do not effect the release of Fe'+ from transferrin at mildly acidic pH by enhancing Fe3+ labilization. Furthermore, this data suggests that approximately four times more labile Fe3+ is available from holosaturated transferrin than from partially saturated transferrin at pH 7.4. As the pH at physiologic levels of iron saturation at pH 7.4. This is in agreement with a previous report by Biemond et al. (16) which suggests that at physiologic pH, stimulated PMNs failed to mobilize iron from partially saturated (60%) transferrin. Furthermore, previous studies at physiologic pH by Aruoma et al. (24) provide indirect evidence that is consistent with the hypothesis that O;, in the presence of EDTA, only minimally mobilizes iron from saturated transferrin.
Other studies have shown that 0; does not directly react with 50% iron-saturated transferrin (25) . As a result of these findings, the role of transferrin as a source of iron for biological reactions at sites of acute inflammation has been questioned (16, 26) . As an extension of these studies, we determined the effect of decreasing the pH on the ability of PMN-derived 0, to facilitate the release of Fe'+ from holosaturated transferrin and from transferrin at physiologic levels of iron saturation. It has been demonstrated that iron release from transferrin can be modulated by several factors including pH (2, 3, 6, 27) . As the pH is decreased, the stability of the Fe3+ transferrin . bicarbonate complex decreases, rendering the metal susceptible to reduction (3). We found that decreasing the pH to 6.6 and 6.2 facilitated the release of Fe'+ from holosaturated transferrin by unstimulated and PMA-stimulated PMNs. The enhanced release of Fe'+ under mildly acidic conditions occurred despite a decrease in the amount of 0; generated by PMAstimulated cells, indicating an increased efficiency in O,-dependent reduction of Fe3+. Our results are consistent with those of Saito et al. (26) 
